Document ID: chunk:federal_register_of_legislation:F2025C00098:body:0:p7
Version: federal_register_of_legislation:F2025C00098
Segment Type: other
Provision Reference: 
Character Range: 15867–18802

relevant subsection 99(2AA), of the Act or subsection 99(4) of the Act.

If the co‑payment is for a general patient under paragraph 11(3)(b)

 (5) If the amount that a CTG supplier is entitled to charge for the supply by the supplier of a pharmaceutical benefit under this Special Arrangement is equal to the concessional beneficiary charge under paragraph 11(3)(b), the supplier is entitled to be paid by the Commonwealth the amount (if any) by which the price of the pharmaceutical benefit under subsection 84C(7) of the Act exceeded the amount charged.

Note: Approved pharmacists who make ACSS eligible supplies may also be entitled to ACSS payments under section 99AAAA of the Act.

14 Claim for payment

 (1) A CTG supplier who wants to receive payment from the Commonwealth for the supply of a pharmaceutical benefit under this Special Arrangement must make a claim for payment to the Chief Executive Medicare on behalf of the Secretary.

 (2) The claim must be made in accordance with the rules made under subsections 98AC(4) and 99AAA(8) of the Act with the following modifications:
 (a) if it is for the supply of a pharmaceutical benefit under paragraph 11(2)(b) or 11(3)(b) — in accordance with those rules, as if the supply were a supply to which Part VII of the Act applies;
 (b) if made using the manual system referred to in section 99AAA of the Act— must include an indicator that the claim is being made for the supply of a pharmaceutical benefit under this Special Arrangement.

Part 2—Application, saving and transitional provisions

Division 1—Transitional provisions relating to old Special Arrangement

15 Definitions

  In this Division:
transition time means the time this section commences;
old Special Arrangement means this Special Arrangement, as in force immediately before the transition time;

Note   This Special Arrangement was previously known as the National Health (Indigenous Chronic Disease – PBS Co‑payment Measure) Special Arrangement 2016.
new Special Arrangement means this Special Arrangement, as amended by the National Health (Closing the Gap – PBS Co‑payment Program) Amendment Special Arrangement 2021.

18 Registration of patients

Despite the amendments made by the National Health (Closing the Gap – PBS Co‑payment Program) Amendment Special Arrangement 2021, a person who was registered under section 10 of the old Special Arrangement is taken to be registered under section 10 of the new Special Arrangement.

Endnotes

Endnote 1—About the endnotes

The endnotes provide information about this compilation and the compiled law.

The following endnotes are included in every compilation:

Endnote 1—About the endnotes
Endnote 2—Abbreviation key
Endnote 3—Legislation history
Endnote 4—Amendment history

Abbreviation key—Endnote 2
The abbreviation key sets out abbreviations that may be used in the endnotes.

Legislation history and amendment history—Endnotes 3 and 4
Amending